Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Bethany Stennett

University of Florida | UF · Department of Clinical and Health Psychology PhD

Biography

Dr. Stennett received her bachelor’s degree from Auburn University in 2011. She then completed her master’s degree jointly at University on North Florida and The Mayo Clinic – Jacksonville in 2013. There, her research focused on novel therapies for nicotine addiction in alcohol dependent rats. In 2018, Dr. Stennett completed her Ph.D. at the University of Florida. Her dissertation research focused on the effects of simultaneous cocaine and alcohol self-administration on striatal glutamate. In August of 2018, she joined the Center for Pain Research and Behavioral Health as a Post-Doctoral Associate. 
Publications

Novel Therapy for Nicotine Addiction in Alcohol Dependent Rats

Background: NT69L, a non-selective neurotensin agonist, provides a potential novel therapy for nicotine addiction in alcoholics by interacting with the common neurotransmitter circuits supporting the rewarding process for both nicotine and alcohol. Considering the behavioral effects of NT69L in attenuating nicotine self-administration in rats and a... Read More»

Mona Boules, Bethany Stennett, Naveen Muhktar, Zhimin Li, Shui Cai and Elliott Richelson

Research Article: J Addict Res Ther 2013, 4: 161

DOI: 10.4172/2155-6105.1000161

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Global Speakers in the subject

Global Experts in the subject

Relevant Topics
Top